Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

Matthew Dunay

Goodwin Procter

main

Dunay Matthew

Goodwin Associate Matthew Dunay, from New York, practices in Business Law with an emphasis on tax. Learn more about Matthew's experience and cases today.

Matthew Dunay

Areas of Practice

Credentials

Education

JD2017

BAMathematics2013

Admissions

Bars

Related Content

New IRS and FinCEN Reporting Requirements for Businesses that Accept Payments in Digital Assets

Highlights From The Final Carried Interest Regulations

HSCM Bermuda Closes New Life Insurance-Focused Continuation Fund with StepStone as Lead Investor

Q32 Bio and Homology Medicines To Merge

Graphite Bio and LENZ Therapeutics To Merge

The Best Lawyers in America 2024 Recognizes 321 Goodwin Lawyers Across 70 Practice Areas

Evelo Biosciences $25.5 Million Private Placement

TCR² Therapeutics and Adaptimmune Enter Into Strategic Combination To Create A Preeminent Cell Therapy Company For Solid Tumors

Neuberger Berman Raises $4.9 Billion for Fifth Global Private Equity Secondary Fund

North Island Ventures Closes Second Venture Fund with $125 Million in Commitments

Tax